Profound Medical Corp (PROF) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $7.78
• Market Cap: $268.57M
• EPS: $-1.32
• 52-Week High: $8.95
• 52-Week Low: $3.76

Market Sentiment

Profound Medical Corp currently has a Neutral sentiment score of -0.09.

About Profound Medical Corp

Profound Medical Corp. is a leading Canadian medical technology company headquartered in Mississauga that specializes in developing advanced therapeutic solutions for prostate cancer. The company's flagship TULSA-PRO system uniquely integrates real-time MRI imaging with ultrasound technology, enabling precise targeting of prostate tissue while safeguarding adjacent healthy structures. Committed to enhancing patient outcomes through minimally invasive procedures, Profound is at the forefront o...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Profound Medical Corp and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PROF pay dividends?

Profound Medical Corp (PROF) does not currently pay a regular dividend.

What is PROF's market cap?

Profound Medical Corp (PROF) has a market capitalization of $268.57M with a current stock price of $7.78.